Francis Collins remains NIH chief, but billions of dollars in cuts could be on the way.

The CEO of Akari Therapeutics has quit amid a probe into the release of phase 2 data and a related analyst report.

Sunovion released some devastating news ahead of the holiday weekend, as the FDA threw a spanner into its plans to bring a new drug for chronic obstructive…

Kite Pharma has secured a priority review at the FDA for its CAR-T candidate.

Scott Gottlieb, M.D., has ended the hiring freeze President Donald Trump imposed on the FDA.

GW Pharma's cannabis-based epilepsy treatment Epidiolex is firmly on track for a filing in the U.S. after new data published in the New England Journal of…

A panel of experts voted 12 to 4 in favor of approving Puma's breast cancer adjuvant therapy neratinib.

​​​​​​​Cel-Sci’s pitch to get a partial clinical hold lifted by the FDA has gone awry.

President Donald Trump’s administration has released a breakdown of its attempts to cut back on healthcare and research spending across the government, with…

Shares in Puma Biotechnology jumped 40% after the FDA trod lightly around doubts about its filing for approval of breast cancer drug neratinib.

Regulatory